TCI1, If Hikma is the company that negotiated the exclusive contract with CVS, it will come out in discovery. Negotiating an exclusive contract with a provider would certainly be considered an overt act. It guarantees infringement. I think Hikma is fucked regardless. Sleven,
Laying in bed this morning thinking specifically about this. It is hard to believe that with an arrangement such as this (no brand V only GV covered) that a large percentage of those scripts are for the CVD indication and are clearly infringement on valid patents.